Edition:
United States

Sun Pharmaceutical Industries Ltd (SUN.BO)

SUN.BO on Bombay Stock Exchange

543.95INR
6:28am EDT
Change (% chg)

Rs5.25 (+0.97%)
Prev Close
Rs538.70
Open
Rs538.90
Day's High
Rs545.10
Day's Low
Rs537.00
Volume
373,502
Avg. Vol
474,011
52-wk High
Rs854.50
52-wk Low
Rs493.00

Latest Key Developments (Source: Significant Developments)

Sun Pharma enters into deal to buy 85.1 pct of Russia's JSC Biosintez
Tuesday, 22 Nov 2016 09:51pm EST 

Sun Pharmaceutical Industries Ltd : Says company has entered into an agreement to acquire 85.1% of JSC Biosintez, a Russian pharmaceutical company . Days deal expected to be completed by end of 2016 . Equity consideration for shares acquired is RUB 1,526 million or approx. USD 24 million .Sun Pharma would also assume a debt of approximately USD$ 36 million as part of this transaction.  Full Article

Sun Pharmaceutical Industries signs tri-party agreement to launch malaria free India
Tuesday, 15 Nov 2016 03:41am EST 

Sun Pharmaceutical Industries Ltd : Sun Pharmaceutical Industries Ltd says Sun Pharma signing tri-party agreement to launch malaria free India . Sun Pharmaceutical Industries -agreement allows other government or private stakeholders to join Mandla project,similar project in partnership with FDEC-India . Sun Pharmaceutical Industries - ICMR, government of MP, FDEC-India sign tri-party agreement to launch malaria free India demonstration project in Mandla district .Sun Pharmaceutical Industries - project to be launched across 1,233 villages in Mandla by january 2017.  Full Article

Beijing Science Sun Pharmaceutical unit to pay penalty of 0.3 mln yuan
Friday, 19 Aug 2016 04:05am EDT 

Beijing Science Sun Pharmaceutical Co Ltd <300485.SZ>: Says its unit received report of administrative punishment from environmental protection department .Says the unit was ordered to pay penalty of about 0.3 million yuan regarding its wastewater discharge.  Full Article

Sun Pharmaceutical Industries June-qtr consol profit rises almost fourfold
Friday, 12 Aug 2016 04:46am EDT 

Sun Pharmaceutical Industries Ltd : June-quarter consol net profit 20.34 billion rupees . June-quarter consol total income from operations 82.43 billion rupees . June-quarter net profit consensus forecast was 19.04 billion rupees . Consol net profit in June-quarter last year was 5.56 billion rupees as per Ind-AS; consol net sales was 67.61 billion rupees .  Full Article

Sun Pharmaceutical extends Imatinib Mesylate Savings Card program benefits for patients in USA
Monday, 8 Aug 2016 08:32am EDT 

Sun Pharmaceutical Industries Ltd : Sun Pharma extends Imatinib Mesylate Savings Card program benefits for patients in USA . Co will continue to offer up to US$ 700 reduction on each eligible patient's initial out-of-pocket cost from their commercial insurer . Benefit will cover a patient's monthly fills for a 30-day supply of Sun pharma's imatinib mesylate prescribed for ph+cml, . Will also continue hub service wherein patients can call and speak with a trained healthcare professional .  Full Article

India's Sun Pharma gets FDA nod for generic Glumetza
Monday, 1 Aug 2016 11:44pm EDT 

Sun Pharmaceutical Industries Ltd : Sun Pharma announces U.S. FDA approval for generic Glumetza . The commercial launch of the tablets in the U.S. is expected over the next few weeks .  Full Article

Sun Pharma and Almirall signs license deal for Psoriasis treatment
Wednesday, 27 Jul 2016 10:32pm EDT 

Sun Pharmaceutical Industries Ltd : Almirall and Sun Pharma enter into a license agreement for Tildrakizumab in Europe for Psoriasis . To receive development & regulatory milestone payments, royalties, the terms of which are confidential .  Full Article

Almirall signs license deal with Sun Pharma for psoriasis treatment
Wednesday, 27 Jul 2016 11:57am EDT 

Almirall SA : Says enters into a license agreement with Sun Pharma Industries for tildrakizumab in Europe for psoriasis . Says to pay Sun Pharma an initial upfront payment of $50 million . Says Sun Pharma will be eligible to get milestone payments, sales milestone payments and royalties on net sales .Says phase-3 studies of tildrakizumab have recently been completed.  Full Article

Sun Pharma signs 410 mln rupees deal with RPG Life Sciences
Wednesday, 27 Jul 2016 06:57am EDT 

Sun Pharmaceutical Industries Ltd : Signed an agreement with RPG Life Sciences Ltd to divest seven prescription brands in India . Deal for a consideration of 410 million rupees . 7 divested brands include brands used for treatment of respiratory-track infections, urological disorders, cardiovascular diseases and brands in health supplements segment .  Full Article

Sun Pharma Industries gets USFDA nod for generic Crestor
Wednesday, 20 Jul 2016 02:25am EDT 

Sun Pharmaceutical Industries Ltd : Gets final approval from USFDA for generic Crestor .  Full Article

More From Around the Web

BRIEF-Sun Pharma Industries gets members' nod for scheme of arrangement with Sun Pharma Medisales, Ranbaxy Drugs, others

* Gets members' nod for scheme of arrangement among Sun Pharma Medisales, Ranbaxy Drugs, Gufic Pharma, Vidyut Investments, co Source text - (http://bit.ly/2tQBUuR) Further company coverage: